---
title: "CVS Health Updates 2025 Guidance; Issues 2026 Outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/269080654.md"
description: "CVS Health has updated its 2025 financial guidance, increasing its adjusted EPS range to $6.60-$6.70 and adjusted operating income to $14.22-$14.39 billion. Total revenue guidance is raised to at least $400 billion. For 2026, CVS projects total revenues of at least $400 billion, adjusted operating income of $15.07-$15.41 billion, and adjusted EPS of $7.00-$7.20. The company also launched a new technology service, \"Engagement as a Service.\" CVS shares rose 3% to $79.00 in pre-market trading."
datetime: "2025-12-09T11:56:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/269080654.md)
  - [en](https://longbridge.com/en/news/269080654.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/269080654.md)
---

# CVS Health Updates 2025 Guidance; Issues 2026 Outlook

Add  as your preferred news source on Google

 Add Now

CVS Health (CVS) said, for 2025, it increased adjusted EPS guidance range to $6.60 to $6.70 from $6.55 to $6.65. The company raised adjusted operating income guidance range to $14.22 billion to $14.39 billion from $14.14 billion to $14.31 billion. Also, total revenues guidance was raised to at least $400.0 billion from at least $397.3 billion. GAAP loss per share is now projected in a range of $0.32 to $0.22, revised from previous guidance of a loss of $0.34 to $0.24.

The company initiated its 2026 full-year financial guidance with: total revenues of at least $400.0 billion; adjusted operating income guidance range of $15.07 billion to $15.41 billion; GAAP EPS guidance range of $5.94 to $6.14; and adjusted EPS guidance range of $7.00 to $7.20.

CVS Health expects to achieve a mid-teens adjusted EPS CAGR through 2028.

CVS Health also announced the launch of a new technology products and services offering, focusing on Engagement as a Service.

Shares of CVS are up 3% to $79.00 in pre-market trade on Tuesday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)

## Related News & Research

- [How Safe Is CVS Health's Dividend?](https://longbridge.com/en/news/287963177.md)
- [08:00 ETCVS Health recognized for technology that improves medication safety and patient care](https://longbridge.com/en/news/288064061.md)
- [H1 secures $40M from CVS, proving SaaS startups can still attract investment](https://longbridge.com/en/news/287957008.md)
- [Better Dividend Growth Stock to Buy: CVS Health or UnitedHealth Group?](https://longbridge.com/en/news/288332924.md)
- [Lilly's GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans](https://longbridge.com/en/news/287961071.md)